KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Inventory (2016 - 2025)

Thermo Fisher Scientific's Inventory history spans 17 years, with the latest figure at $5.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 8.98% year-over-year to $5.4 billion, compared with a TTM value of $5.4 billion through Dec 2025, up 8.98%, and an annual FY2025 reading of $5.4 billion, up 8.98% over the prior year.
  • Inventory for Q4 2025 was $5.4 billion at Thermo Fisher Scientific, down from $5.7 billion in the prior quarter.
  • The five-year high for Inventory was $5.7 billion in Q3 2025, with the low at $13.0 million in Q4 2021.
  • Average Inventory over 5 years is $5.1 billion, with a median of $5.4 billion recorded in 2023.
  • Year-over-year, Inventory tumbled 99.66% in 2021 and then skyrocketed 43915.38% in 2022.
  • Tracing TMO's Inventory over 5 years: stood at $5.1 billion in 2021, then rose by 11.54% to $5.6 billion in 2022, then fell by 9.69% to $5.1 billion in 2023, then fell by 2.16% to $5.0 billion in 2024, then rose by 8.98% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Inventory are $5.4 billion (Q4 2025), $5.7 billion (Q3 2025), and $5.6 billion (Q2 2025).